Description: Gemelli Biotech leverages leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide and post-infectious IBS.
research (8957) biotechnology (824) ibs (324) gut (308) microbiome (142) sibo (57) gemelli (16) scientific discovery (6) gemlli biotech (1)
PARTNERSHIPS
PRECISION DIAGNOSTICS FOR GI DISEASES
To leverage leading biological discoveries related to the microbiome to provide non-invasive precision diagnostics which enable clinicians to definitively detect scientifically validated biomarkers and optimally treat GI diseases including SIBO, IMO, excess hydrogen sulfide and post-infectious IBS.